Evidence map›Paper›PMID 40877735›Full record

ArticleJournal of gastrointestinal cancer2025

Population-Based Analysis of the Interplay between Rurality and Race in Gastric Adenocarcinoma Survival.

Nicole M Hwang, Matthew E B Dixon

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of gastrointestinal cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Nicole M HwangRush Medical College, Chicago, IL, USA. Nicole_Hwang@rush.edu.
Matthew E B DixonDepartment of Surgery, Division of Surgical Oncology, Rush University Medical Center, Chicago, IL, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeDespite growing efforts to understand how rurality impacts cancer outcomes, significant gaps remain in understanding its prognostic influence and its interaction with race in patients with gastric adenocarcinoma (GA).

methodsUsing the Surveillance, Epidemiology, and End Results (SEER) database, we evaluated the impact of rurality on cancer-specific survival (CSS) in 45,589 GA patients using Kaplan-Meier methods. A multivariable Weibull regression survival model was used to control for potential confounders. We assessed the interplay between race and rurality by evaluating how the association of rurality on CSS differed across race-stratified groups and through joint-effects analysis.

resultsMost patients lived in urban areas (89.5% vs 10.5%). There were no significant differences in age and receipt of chemotherapy between rural and urban populations. Rural patients tended to be male, non-Hispanic White, and more likely to have received radiation but less likely to have undergone surgery. Patients residing in rural areas had significantly worse CSS [hazard ratio (HR) = 1.16; 95% CI: 1.12-1.20; p < 0.001] even after adjusting for potential confounders [adjusted HR = 1.15; 95% CI: 1.11-1.19; p < 0.001]. After stratifying by race, the impact of rurality was not observed in non-Hispanic Black patients (p = 0.223) and was most pronounced in non-Hispanic Asian and Pacific Islanders (p = 0.019).

conclusionsRurality was associated with worse prognosis in GA patients across most racial groups. These findings highlight the need for further research to understand the mechanisms underlying urban-rural disparities in GA outcomes to identify targeted interventions.

Indexed as

AdenocarcinomaRural PopulationStomach NeoplasmsAgedFemaleHumansKaplan-Meier EstimateMaleMiddle AgedPrognosisSEER ProgramSurvival RateUnited StatesUrban PopulationCancer disparitiesGastric cancerRuralitySurvival outcomes

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.